Gamida, college unveil study of gene therapy for blood diseases

12/3/2009 | Globes (Israel)

Israel-based Gamida Cell and the Weill Cornell Medical College have unveiled a feasibility study to test the safety and effectiveness of a gene treatment that could be used to treat beta thalassemia and other forms of congenital anemia. The gene therapy uses technologies developed by Gamida and Weill Cornell.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC